论文部分内容阅读
目的:检验盐酸溴己新、依诺沙星注射液与注射用丹参(冻干)注射剂,是否存在配伍禁忌,消除临床用药安全隐患,确保临床用药安全。方法:临床试验法,用一次性无菌注射器2支,分别抽取依诺沙星注射液1ml,盐酸溴己新1ml,配制好的丹参(冻干)注射剂注射液1ml两两相混在一起,观察其性状、颜色的变化。结果:证实了注射用用丹参(冻干)与依诺沙星注射液,注射用用丹参(冻干)注射剂与盐酸溴己新注射液,存在着配伍禁忌。结论:近年来新药不断出现,而为了达到治疗效果联合用药较为常见。而应用配伍禁忌表中新药显示资料不足,可供查阅的资料也不多,遇到这种情况,我们可以采用临床试验法来证实这些新药是否与其它药物存在配伍禁忌,此方法简单易行。
Objective: To test whether bromhexine hydrochloride, enoxacin injection and injection of Salvia miltiorrhiza (lyophilized) injection have compatibility contraindications to eliminate the hidden dangers of clinical medication and ensure the safety of clinical medication. Methods: Clinical trial, with two disposable sterile syringes, respectively, enoxacin injection 1ml, bromhexine hydrochloride 1ml, prepared Salvia (lyophilized) injection injection 1ml two pairs of mixed together to observe Its traits, color changes. Results: Confirmed the injection with Salvia (freeze-dried) and enoxacin injection, injection with Salvia (freeze-dried) injection and bromhexine hydrochloride injection, there are compatibility taboo. Conclusion: In recent years, new drugs continue to appear, and in order to achieve the therapeutic effect of combination therapy is more common. The application of incompatible taboos in the table shows the lack of new drugs, available for access to information is not much, in this case, we can use clinical trials to confirm whether these new drugs with other drugs compatibility taboo, this method is simple and easy.